NCT03203239View on ClinicalTrials.gov

Red Light Treatment in Peripheral Artery Disease

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Peripheral Artery DiseaseClaudication, IntermittentVasodilation
Interventions
DEVICE

Red Light (670 nm energy)

Light Emitting Diode light source (670 nm wavelength with output up to 75mW/cm2) will be placed over the gastrocnemius muscle. The light will be on for 5 minutes.

DRUG

Octafluoropropane

All subjects will undergo infusion of octafluoropropane to measure peripheral blood flow.

Trial Locations (1)

53226

RECRUITING

Medical College of Wisconsin, Milwaukee

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER